go-v.orgdoi

Reliability and Accuracy of Point-of-Care Amino-Terminal ProBrain Natriuretic Peptide in Congestive Heart Failure Patients

— · The Internet Journal of Cardiology · 2010

  • DOI 10.5580/72f
  • Publisher OpenAlex
  • Type article
  • Issued 2010

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

The Internet Journal of Cardiology · OpenAlex · article · 2010

Abstract

Background: Globally, role of amino-terminal pro-brain natriuretic peptide (NT pro-BNP) in diverse aspects of Congestive Heart Failure (CHF) has gained near-consensus status. Such experience is rare in many parts of Africa, and levels may be affected by ethnicity. Aim/Objectives: To determine NT pro-BNP levels in Nigerian healthy adults and hospitalised CHF patients; in order to establish its diagnostic accuracy. Methods: Controls and CHF patients were examined clinically, with trans-thoracic echocardiography; while plasma NT pro-BNP was measured by a point-of care-immunoassay system (Cardiac Reader).

We compared the diagnostic performance of our study-derived NT pro-BNP reference value with others. Main outcome: Obtain reference value of NT pro-BNP and compare its diagnostic performance with recommended product value of 125 pg/mL. ResultsParticipants were 42 CHF patients matched for age (p=0.26) and gender (p=0.78) with 30 controls. NT pro-BNP levels of controls differed significantly by gender (females: 64.8 ±12.3 versus males: 98.2 (54.8), p<0.05); and by CHF status (86.43±43.6 versus 1915 ±1082.1 pg/mL, p<0.001). NT pro-BNP demonstrated negative correlation with left ventricular function (r=-0.5, p<0.05).

Our study NT pro-BNP reference value of 171 pg/mL yielded sensitivity, specificity, NPV, PPV of 88.1%, 93.3%, 90.3%, 95.2%, respectively, performing better than manufacturer’s recommended value of 125 pg/mL( sensitivity 85.7%, specificity 86.7%, NPV 87.1%, and PPV 92.5% respectively. Conclusions: NT pro-BNP values were significantly higher in CHF patients; and demonstrated significant negative association with left ventricular function. Our point-of care reference value demonstrated better diagnostic performance than manufacturer’s cut-off value. This calls for further local studies, using the new cut-off value.

Open the resolved locator · 10.5580/72f

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 01:05 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
http://doi.org/10.5580/72f
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.